Cardiovascular disease epidemiology: A journey from the past into the future

Circulation

Volumn 93, Issue 9, 1996, Pages 1755-1764

  Epstein, Frederick H ^a   Blackburn, Henry ^b   Gutzwiller, Felix ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CORONARY ARTERY DISEASE; CORONARY RISK; FAT INTAKE; HEALTH BEHAVIOR; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL RESEARCH; PRIORITY JOURNAL;

EID: 0029873948     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.9.1755     Document Type: Article

References (83)

1. Keys A, Taylor HL, Blackburn H, Brozek J, Anderson JT, Simonson E. Coronary heart disease among Minnesota business and professional men followed 15 years. Circulation. 1963;28: 381-395.
2. Dawber TR. The Framingham Study: The Epidemiology of Atherosclerotic Disease. Cambridge/London: Harvard University Press; 1980.
3. Keys A. The inception and pilot surveys. In: Kromhout D, Menotti A, Blackburn H, eds. The Seven Countries Study: A Scientific Adventure in Cardiovascular Epidemiology. Utrecht, Netherlands: Brouwer Offset bv; 1994:15-27.
4. Keys A, White PD. Cardiovascular Epidemiology. New York, NY: Paul B. Hoeber; 1956.
5. Cooperative Study of Lipoproteins and Atherosclerosis. Evaluation of serum lipoprotein and cholesterol measurements as predictors of clinical complications of atherosclerosis. Circulation. 1956;14(part II):691-741.
6. Gofman J, Lindgren F, Elliott H, Mantz W, Hewitt J, Strisower B, Herring V. The role of lipids and lipoproteins in atherosclerosis. Science. 1950;111:166-171.
7. Cohn AE, Ling C. The Burden of Diseases in the United States. New York, NY: Oxford University Press; 1950.
8. Adlersberg D, Parets AD, Boas EP. Studies of families with xanthoma and unselected patients with coronary artery disease under the age of 50 years. JAMA. 1949;141:246-254.
9. Blackburn H. Introduction to Ancel Keys Lecture: Ancel Keys, pioneer. Circulation. 1991;84:1402-1404.
10. Hirsch A. Handbook of Geographical and Historical Pathology. Translated by Charles Creighton. London, England: The New Sydenham Society; 1883.
11. Raab W. Alimentäre Faktoren in der Entstehung von Arteriosklerose und Hypertonie. Med Klin. 1932;28:487-521.
12. Rosenthal SR. Studies in atherosclerosis: chemical, experimental and morphological: roles of cholesterol metabolism, blood pressure and structure of aorta, fat angle of aorta (FAA) and infiltration-expression theory of lipid deposit. Arch Pathol. 1934;18:473 and 660.
13. Anitschkow N. Pathologische Anatomie und allgemeine Pathologie der Arteriosklerose. In: Askanazy M, ed. Deuxième Conférence Internationale de Pathologie Géographique. Utrecht, Netherlands: A. Oosthoek; 1934:44-101.
14. Keys A. Seven Countries. A Multivariate Analysis of Death and Coronary Heart Disease. Cambridge/London: Harvard University Press; 1980.
15. Keys A. Atherosclerosis: a problem in newer public health. J Mt Sinai Hosp. 1953;20:118-139.
16. Yerushalmi J, Hilleboe HE. Fat in the diet and mortality from heart disease. NY State J Med. 1957;57:2343-2354.
17. Keys A, Anderson JT, Grande F. Serum cholesterol response to changes in the diet, IV: particular fatty acids in the diet. Metabolism. 1965;14:776-787.
18. Keys A. Coronary heart disease in seven countries. Circulation. 1970;41(suppl I):I-1-I-211.
19. Epstein FH. Public health implications of the Seven Countries Study. In: Kromhout D, Menotti A, Blackburn H, eds. The Seven Countries Study: A Scientific Adventure in Cardiovascular Disease Epidemiology. Utrecht, Netherlands: Brouwer Offset bv; 1994: 169-174.
20. Stamler J. Population Studies. In: Levy R, Rifkind B, Dennis B, Ernst N, eds. Nutrition, Lipids, and Coronary Heart Disease. New York, NY: Raven Press; 1979:25-88.
21. Liu K, Stamler J, Trevisan M, Moss D. Dietary lipids, sugar, fiber and mortality from coronary heart disease: bivariate analysis of international data. Arteriosclerosis. 1982;2:221-227.
22. Artaud-Wild SM, Connor SL, Sexton G, Connor WE. Differences in coronary mortality can be explained by differences in cholestero and saturated fat intakes in 40 countries but not in France and Finland. Circulation. 1993;88:2771-2779.
23. Simons LA. Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol. 1985;57: 5G-10G.
24. Law MR, Wald NJ. An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990. Eur J Clin Nutr. 1994;48:305-325.
25. Epstein FH. Myocardial infarction in Europe: geographical differences and time trends. In: Mason DT, Neri-Serneri GG, Oliver MF, eds. Florence International Meeting on Myocardial Infarction. Amsterdam/Oxford/Princeton: Excerpta Medica; 1979:11-21.
26. World Health Statistics Quarterly. Vol 41. Geneva, Switzerland: World Health Organization; 1988.
27. World Health Statistics Annual. Geneva, Switzerland: World Health Organization; 1989.
28. Stewart AW, Kuulasma K, Beaglehole R. Ecological analysis of the association between mortality and major risk factors of cardiovascular disease: the World Health Organization MONICA Project. Int J Epidemiol. 1994;23:505-516.
29. Menotti A, Seccareccia F. Risk factors and mortality patterns in the Seven Countries Study. In: Toshima H, Koga Y, Blackburn H, Keys A, eds. Lessons for Science From the Seven Countries Study. Tokyo/ Berlin/Heidelberg/New York: Springer; 1994:17-34.
30. Papers from a workshop on Trends and Determinants of Coronary Heart Disease Mortality: International Comparisons. Int J Epidemiol. 1989;18(suppl 1):S1-S230.
31. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Jousilathi P. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. Br Med J. 1994;309:23-27.
32. Higgins MW, Luepker RV. Trends in Coronary Heart Disease Mortality: The Influence of Medical Care. New York, NY: Oxford University Press; 1988.
33. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr. 1991;53(1 Suppl):326S-334S.
34. Tunstall-Pedoe H, Kuulasma K, Amouyel P, Arveiler D, Rajakangas A-M, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
35. Keys A. The physiology of the individual as an approach to a more quantitative biology of man. Fed Proc. 1949;8:523-529.
36. Measuring the risk of coronary heart disease in adult population groups: a symposium. Am J Public Health. 1957;47:1-63.
37. Kannel WB, Dawber TR, Kagan A, Revotskie L, Stokes J III. Factors of risk in the development of coronary heart disease: six-year follow-up experience. Ann Intern Med. 1961;55:33-50.
38. Epstein FH. Predicting coronary heart disease. JAMA. 1967;201: 795-800.
39. Epstein FH. Predicting, explaining, and preventing coronary heart disease. Mod Concepts Cardiovasc Dis. 1979;48:7-12.
40. Epstein FH. Coronary heart disease epidemiology revisited: clinical and community aspects. Circulation. 1973;48:185-194.
41. Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J. 1981;1:1847-1851.
42. Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985;14:32-38.
43. WHO Scientific Group. Cardiovascular Disease Risk Factors: New Areas for Research. Geneva, Switzerland: World Health Organization; 1994.
44. Postiglione A, Panico S, Lewis B, Eisenberg S, Fruchart JC, Hanefeld M, Heistad DD, Kesaniemi YA, Mann JI, Olsson AG, Paulson OB, Rossouw JE, Seidel D, Singh RB. New and candidate risk factors for coronary heart disease. Nutr Metab Cardiovasc Dis. 1994;4:233-255.
45. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994;308:367-372.
46. Holme I. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. Circulation. 1990;82:1916-1924.
47. Tyroler HA. Review of lipid-lowering clinical trials in relation to observational studies. Circulation. 1987;76:515-522.
48. Collins R, Keech A, Peto R, Sleight P, Kjekshus J, Wilhelmsen L, MacMahon S, Shaw J, Simes J, Braunwald E, Buring J, Hennekens C, Pfeffer M, Sacks F, Probstfield J, Yusuf S, Downs JR, Gotto A, Cobbe S, Ford I, Shepherd J. Cholesterol and total mortality: need for larger trials. BMJ. 1992;304:1689. Letter.
49. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344: 1383-1389.
50. Mass Field Trials of the Diet-Heart Question: Their Significance, Feasibility and Applicability. Report of the Diet-Heart Review Panel of the National Heart Institute. American Heart Association Monograph No. 28, June 1969.
51. Johnson CL, Rifkind BM, Sempos CT, Carrol MD, Bachoric PS, Briefel RR, Gordon DJ, Burt VL, Brown CD, Lippel K, Cleeman JI. Declining serum total cholesterol levels among US adults: the National Health and Nutrition Surveys. JAMA. 1993;269:3002-3008.
52. Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J, Nissinen A. Twenty-year trends in coronary risk factors in North Karelia and other areas of Finland. Int J Epidemiol. 1994;23:495-504.
53. Thom TJ. International mortality from heart disease: rates and trends. Int J Epidemiol. 1989;18(suppl 1):S20-S28.
54. Epstein FH. Low cholesterol, cancer, and other non-cardiovascular disorders. Atherosclerosis. 1992;94:1-12.
55. Epstein FH. Interpreting the association between low serum cholesterol and disease: confounding and causality. In: Lewis B, Paoletti R, Tikkanen MJ, eds. Low Blood Cholesterol: Health Implications. London, England: Current Medical Literature Ltd; 1993:10-17.
56. National Cholesterol Education Program. Second Report of the Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II). Circulation. 1994; 89:1329-1445.
57. Pyörälä K, De Backer G, Poole-Wilson P, Wood D, on behalf of the Task Force. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society, and European Society of Hypertension. Eur Heart J. 1994;15:1300-1331.
58. Francis T Jr. Aspects of the Tecumseh Study. Public Health Reports. 1961;76:963-966.
59. Francis T Jr. The epidemiological approach to human ecology. Am J Med Sci. 1959;237:677-684.
60. Epstein FH, Francis T Jr, Hayner NS, Johnson BC, Kjelsberg MO, Napier JA, Ostrander LD Jr, Payne MW, Dodge HJ. Prevalence of chronic diseases and distribution of selected physiologic variables in a total community: Tecumseh, Michigan. Am J Epidemiol. 1965;81: 307-322.
61. Epstein FH. Prevention of coronary heart disease: links with other chronic disorders. In: Lenzi S, Descovitch GC, eds. Atherosclerosis and Cardiovascular Disease. Lancaster/Boston/The Hague/ Dordrecht: MTP Press Ltd; 1987:157-162.
62. Epstein FH. Will measures to prevent coronary heart disease protect against other chronic disorders? In: Toshima H, Koga Y, Blackburn H, Keys A, eds. Lessons for Science from the Seven Countries Study. Tokyo/Berlin/Heidelberg/New York: Springer; 1994:179-193.
63. Sauer HI, Enterline PE. Are geographic variations in death rates from cardiovascular disease real? J Chron Dis. 1959;10:513-524.
64. Sidney S, Farquhar JW. Cholesterol, cancer and public health policy. Am J Med. 1983;75:494-508.
65. Menotti A, Conti S, Giampaoli S, Mariotti S, Signoretti P. Coronary risk factors predicting coronary and other causes of death in fifteen years. Acta Cardiol. 1980;35:107-120.
66. Menotti A, Mariotti S, Seccareccia F, Diampaoli S. The 25-year estimated probability of death from some specific causes as a function of twelve risk factors in middle-aged men. Eur J Epidemiol. 1987;4:60-67.
67. Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R. Relationship of baseline major risk factors to coronary and all-cause mortality and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiology. 1993;82:191-222.
68. Wingard DL, Berkman LF, Brand RJ. A multivariate analysis of health-related practices: a nine-year mortality follow-up of the Alameda County Study. Am J Epidemiol. 1982;116:765-775.
69. Puska P, Korhonen HJ, Torppa J, Tuomilehto J, Vartiainen E, Pietinen P, Nissinen A. Does community-wide prevention of cardiovascular disease influence cancer mortality? Eur J Cancer Prev. 1993;2:457-460.
70. Marmot MG, Shipley MJ, Rose G. Inequalities in death-specific explanations of a general pattern. Lancet. 1984;1:1003-1006.
71. Committee on Diet and Health, Food and Nutrition Board, Commission on Life Sciences, National Research Council. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy Press; 1989.
72. WHO Study Group. Diet, Nutrition, and the Prevention of Chronic Diseases. World Health Organization Technical Report Series 797. Geneva, Switzerland: World Health Organization; 1990.
73. Waldron KW, Johnson IT, Fenwick GR. Food and Cancer Prevention: Chemical and Biological Aspects. Cambridge, England: Royal Society of Chemistry; 1993.
74. Kesteloot H, Lesaffre E, Joosens JV. Dairy fat, saturated animal fat, and cancer risk. Prev Med. 1991;20:226-236.
75. Paffenbarger RS, Hyde RT, Wing AL, Lee I-M, Jung DL, Kampert JB. The association of changes in physical activity level and other lifestyle characteristics with mortality among men. N Engl J Med. 1993;328:538-545.
76. Thom TJ, Kannel WB, Feinleib M. Factors in the decline of coronary heart disease mortality. In: Connor WE, Bristow JD, eds. Coronary Heart Disease: Prevention, Complications, Treatment. Philadelphia, Pa: Lippincott; 1988:5-20.
77. Thom TJ, Epstein FH, Feldman JJ, Leaverton PE, Wolz M. Total Mortality and Mortality From Heart Disease, Cancer and Stroke From 1950 to 1987 in 27 Countries: Highlights of Trends and Their Interrelationships Among Causes of Death. NIH publication No. 92-3088. Bethesda, Md: National Institutes of Health, National Heart, Lung and Blood Institute; 1992.
78. Thom TJ, Epstein FH. Heart disease, cancer, and stroke mortality trends and their interrelationships: an international perspective. Circulation. 1994;90:574-582.
79. Epstein FH, Holland WW. Prevention of chronic diseases in the community: one disease versus multiple disease strategies. Int J Epidemiol. 1983;12:135-137.
80. Glasunov IS, Grabauskas V, Holland WW, Epstein FH. An integrated programme for the prevention and control of non-communicable diseases. J Chron Dis. 1983;36:419-426.
81. Myers GC. International research on healthy life expectance. In: Feinleib M, ed. Comparative International Vital and Health Statistics Report. Series 7, No. 7. Hyattsville, Md: Vital and Health Statistics, DHHS Publication No. (PHS) 93-1483. 1993:33-42.
82. Robine J-M, Blanchet M, Dowd JE. Health Expectancy: First Workshop of the Healthy Life Expectancy Network. London, England: HMSO; 1992.
83. Stallones RA. Patterns of health risk: Seven Countries. Science. 1980;208:1138-1139.